Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
KRRO
#3224
Korro Bio, Inc. Common Stock
12.130
0
+4.39%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+4.39%
Variazione Mensile
+6.22%
Variazione di 6 mesi
-68.82%
Variazione Annuale
-68.82%
Chiusura Precedente
11.620
0
Open
12.130
0
Bid
Ask
Low
12.130
0
High
12.130
0
Volume
27
Mercati
Mercato Azionario Statunitense
Salute
KRRO
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
34.18 M
34.98 M
35.29 M
8.02 M
9.39 M
—
Valuation ratios
Enterprise value
—
—
—
228.05 M
301.79 M
911.66 M
Price to earnings ratio
—
—
—
-0.93
-4.06
-12.29
Price to sales ratio
—
—
—
—
149.54
—
Price to cash flow ratio
—
—
—
1.12
5.65
16.48
Price to book ratio
—
—
—
0.14
0.49
0.74
Enterprise value to EBITDA ratio
—
—
—
-2.81
—
—
Profitability ratios
Return on assets %
0.1
0.46
0.67
0.37
0.37
0.46
Return on equity %
0.14
0.65
1.18
0.48
0.52
0.71
Return on invested capital %
-211.02
-626.33
-671.01
-699.18
-487.96
-380.89
Gross margin %
100
100
—
—
100
400
Operating margin %
-74.49
-597.32
—
—
-4 047.12
-5 623.72
EBITDA margin %
—
—
—
—
—
—
Net margin %
71.68
601.98
—
—
3 680.36
5 272.64
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.45
11.79
4.16
8.87
8.79
30.89
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.15
0.06
0
0
0.01
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.06
0.08
0.03
—
—
—
Long term debt to total equity ratio
0.04
0.03
0.01
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
44
6.73
7.32
EBIT per share
—
—
—
-55.28
—
—
EBITDA per share
—
—
—
-52.97
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
—
108.64
14.14
38.6
Net current asset value per share
—
—
—
112.94
14.74
49.06
Tangible book value per share
—
—
—
350.43
77.75
315.52
Working capital per share
—
—
—
100.2
13.07
42.62
Book value per share
—
—
—
350.43
77.75
315.52
Notizie
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Clear Street alza il rating su Korro Bio per il potenziale del programma iperammonemia
Clear Street upgrades Korro Bio stock rating on hyperammonemia program potential
Strength Seen in Korro Bio, Inc. (KRRO): Can Its 13.9% Jump Turn into More Strength?
H.C. Wainwright alza il rating del titolo Korro Bio a Buy per il potenziale di un nuovo farmaco
Korro Bio stock rating upgraded by H.C. Wainwright to Buy on new drug potential
Piper Sandler alza il rating di Korro Bio a Overweight grazie al trattamento UCD
Piper Sandler upgrades Korro Bio stock rating to Overweight on UCD treatment
Chardan Capital upgrades Korro Bio stock to Buy on KRRO-121 potential
Korro Bio, Inc. (KRRO) Analyst/Investor Day - Slideshow (NASDAQ:KRRO) 2026-01-28
Raymond James riconferma il rating Market Perform per le azioni di Korro Bio
William Blair conferma il rating Market Perform sulle azioni di Korro Bio